Females had higher in-hospital mortality (2.2% vs 1.3%, OR 1.74) but similar 20-year survival after CABG; off-pump CABG reduced female in-hospital mortality to 1.6% vs 3.0% on-pump.
Does female sex worsen perioperative outcomes and long-term survival compared to male sex in patients undergoing isolated CABG?
Females undergoing CABG face higher in-hospital mortality and receive fewer grafts than matched males, though 20-year survival is similar and off-pump CABG may mitigate early mortality risks.
Absolute Event Rate: 0% vs 0%
Objective To evaluate sex differences in perioperative characteristics, in-hospital outcomes and long-term survival following coronary artery bypass grafting (CABG). Methods Prospective data were collected for all patients undergoing isolated CABG at a single centre during 2001–2021. Baseline characteristics were adjusted between females and males using 1:1 propensity score matching (nearest-neighbour, without replacement). Kaplan-Meier analysis assessed long-term survival. A predefined sub-analysis assessed risk mitigation associated with using off-pump CABG (OPCABG) in females in the matched cohort. Results Prematching, 11 563 males and 2573 females were included. Females were older with higher prevalences of class III–IV angina, hypertension and diabetes. After matching, 2573 patients per group were analysed, with standardised mean differences <0.1 for all covariates. Females had fewer left internal mammary artery (LIMA) grafts (84% vs 88%, p<0.001), fewer total grafts (median 2 vs 3, p<0.001), higher in-hospital mortality (2.2% vs 1.3%, OR 1.74, 95% CI 1.14 to 2.71, p=0.011) and longer hospital stays (median 7 days vs 6 days, beta 0.51, 95% CI 0.12 to 0.90, p=0.01). Long-term survival was similar (stratified log-rank p=0.79). OPCABG mitigated the risk of in-hospital mortality in females (1.1% males vs 1.6% females, OR 0.69, 95% CI 0.33 to 1.43, p=0.32; 1.6% OPCABG females vs 3.0% on-pump females, OR 0.53, 95% CI 0.31 to 0.91, p=0.021). Conclusions Females suffer higher in-hospital mortality and receive fewer LIMA and total number of grafts than males; however, 20-year survival is similar. OPCABG protects females from in-hospital mortality. A new female-tailored peri-operative care approach is warranted for females undergoing CABG.
Dixon et al. (Thu,) reported a other. Females had higher in-hospital mortality (2.2% vs 1.3%, OR 1.74) but similar 20-year survival after CABG; off-pump CABG reduced female in-hospital mortality to 1.6% vs 3.0% on-pump.